Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00643149 · ClinicalTrials.gov registry record · Phase 3
A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 693
- Enrollment target
NCT00643149 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 693 participants.
The verdict
NCT00643149, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 693 participants
- Enrollment target
Study Summary
The objective was to determine if a single 60 mg/kg dose of azithromycin SR was as safe and effective as a 10-day regimen of amoxicillin (45 mg/kg/day, given in divided doses every 12 hours) when used to treat children with strep throat.
Interventions
- DRUG amoxicillin
- DRUG azithromycin SR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 693 participants |
| Start Date | 2003-05 |
| Est. Completion | 2004-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00643149
The ClinicalTrials.gov registry entry for NCT00643149 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 693 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which amoxicillin is the first listed.
NCT00643149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00643149 about?
NCT00643149 is a clinical study titled "A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children". The objective was to determine if a single 60 mg/kg dose of azithromycin SR was as safe and effective as a 10-day regimen of amoxicillin (45 mg/kg/day, given in divided doses every 12 hours) when used to treat children with strep throat.
What is the current status of trial NCT00643149?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 693 participants. The study started on 2003-05. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00643149?
The interventions under investigation include: amoxicillin (DRUG), azithromycin SR (DRUG).
Who is sponsoring clinical trial NCT00643149?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.